Drusen proteome analysis: An approach to the etiology of age-related macular degeneration
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index; 3 of the 17 sources its claims cite were checked for support.
Abstract
Drusen are extracellular deposits that accumulate below the retinal pigment epithelium on Bruch's membrane and are risk factors for developing age-related macular degeneration (AMD). The progression of AMD might be slowed or halted if the formation of drusen could be modulated. To work toward a molecular understanding of drusen formation, we have developed a method for isolating microgram quantities of drusen and Bruch's membrane for proteome analysis. Liquid chromatography tandem MS analyses of drusen preparations from 18 normal donors and five AMD donors identified 129 proteins. Immunocytochemical studies have thus far localized ≈16% of these proteins in drusen. Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, and serum albumin were the most common proteins observed in normal donor drusen whereas crystallin was detected more frequently in AMD donor drusen. Up to 65% of the proteins identified were found in drusen from both AMD and normal donors. However, oxidative protein modifications were also observed, including apparent crosslinked species of tissue metalloproteinase inhibitor 3 and vitronectin, and carboxyethyl pyrrole protein adducts. Carboxyethyl pyrrole adducts are uniquely generated from the oxidation of docosahexaenoate-containing lipids. By Western analysis they were found to be more abundant in AMD than in normal Bruch's membrane and were found associated with drusen proteins. Carboxymethyl lysine, another oxidative modification, was also detected in drusen. These data strongly support the hypothesis that oxidative injury contributes to the pathogenesis of AMD and suggest that oxidative protein modifications may have a critical role in drusen formation.
Overview
CoChat Summary
TL;DR
This study developed a method to isolate microgram quantities of drusen and analyzed their proteome by LC MS/MS, identifying 129 proteins from normal and AMD donor eyes. It reports oxidative protein modifications, especially carboxyethyl pyrrole adducts, that are more abundant in AMD Bruch’s membrane, supporting a role for oxidative injury in AMD pathogenesis.
Key findings
- LC MS/MS of drusen preparations from 18 normal donors and five AMD donors identified 129 proteins: 107 from normal donors and 62 from AMD donors. About 38% (41/107) of normal-donor proteins were also found in AMD donors, and 65% (42/62) of AMD-donor proteins were found in normal donors; 21 of 62 AMD proteins (≈33%) were not observed in normal donor drusen.
- TIMP3, clusterin, vitronectin, and serum albumin were the most common proteins in normal donor drusen, detectable in up to 80% of tissues from the 18 normal donors and 60% of drusen preparations from the five AMD donors. Crystallin was detected more frequently in AMD donor drusen.
- Immunocytochemistry localized ≈16% (21/129) of identified proteins in drusen.
- Oxidative modifications were observed, including apparent crosslinked species of TIMP3 and vitronectin and carboxyethyl pyrrole (CEP) protein adducts. By Western analysis, CEP immunoreactivity was present in 9 of 11 AMD samples versus 2 of 11 age-matched controls (Fischer’s test, P = 0.004 single-sided); carboxymethyl lysine was also detected in drusen.
Methods
- Human donor eyes from 29 normal and 16 AMD donors, ages 56–98 years, were used. Drusen isolation and protein identification used 23 eyes (18 normal, five AMD); Western analyses used 22 eyes (11 normal, 11 AMD). Eyes were enucleated 1.5–7 h after death and frozen.
- Drusen were manually isolated from Bruch’s membrane, proteins were extracted, trypsin-digested, and analyzed by liquid chromatography tandem MS (LC MS/MS) with database searching. Immunocytochemistry and Western analysis were used to confirm drusen localization and detect oxidative modifications.
- For CEP Western analysis, Bruch’s membrane/RPE/choroid from AMD and age- and gender-matched normal donors was subjected to SDS/PAGE (≈20 µg protein per lane) and probed with anti-CEP antibodies.
Limitations
- The paper states that mass spectrometric analyses did not measure protein abundance; the number of proteins identified per drusen preparation varied from 0 to 39 and averaged 19. It also notes that some identified proteins may be soluble contaminants or, as with annexin II, localized to RPE tissue adhering to drusen, and that additional AMD donors are required to establish the significance of the crystallin observation.
- The paper states that whether any drusen protein is uniquely associated with AMD remains to be determined.
- Evident from the text: the AMD proteomic group was small (five donors), many isolated drusen were from far peripheral locations, and immunocytochemical confirmation covered only ≈16% of identified proteins.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 1 Not valid · 8 Not checked · 29 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Among the nine identified immunopositive proteins were albumin and 𝛂 1-antitrypsin, both of which were detected in drusen by LC MS ∕ MS (Table 3) and immunocytochemistry (14).”
What the sources say
- Disputedcites [14] matched to “Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease” (2000) sourceExperimental — accuracy not yet measured
Our copy of Mullins et al. (2000) directly contradicts the attributed point: in the Immunohistochemistry section it states that 'Antibodies directed against human serum albumin and haptoglobin bound strongly to the choroidal stroma, but not to hard or soft drusen,' and Table 1 scores Albumin as negative for drusen (figure legend for panel J repeats that labeling was not generally observed with albumin antibodies). Alpha-1-antitrypsin is likewise not presented as an identified drusen component — the same section reports 'Weak and/or inconsistent drusen labeling of antibodies directed against the protease inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin,' and Table 1 lists it as negative with only rare variable reactions. The proteins the paper does identify in all drusen phenotypes are amyloid P component, apolipoprotein E, immunoglobulin light chains, Factor X and complement C5/C5b-9 (Abstract; Immunohistochemistry), and the study contains no carboxyethylpyrrole/CEP-adduct work and no LC-MS/MS data. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The multiple, higher mass electrophoretic components containing these proteins suggest the presence of covalent crosslinks, protein modifications that can be caused by reactive lipid and carbohydrate oxidation products (22, 23).”
What the sources say
- Partly supportedcites [22] Friguet, B., Stadtman, E. R. & Szweda, L. I. (1994) J. Biol. Chem. 269, 21639-21643. sourceExperimental — accuracy not yet measured
Friguet et al. (1994) directly support the lipid-oxidation half of what the paired citation is offered for: the Cross-linking of Glu-6-PDH by HNE section (Fig. 1) shows progressive appearance of higher-mass multimeric (dimeric, tetrameric) protein on SDS-gel filtration and SDS-gel electrophoresis after exposure to the lipid peroxidation product HNE, i.e. covalent cross-links, and the Discussion/Abstract state this explicitly. Our copy contains no passage attributing cross-linking to carbohydrate oxidation products (searched: carbohydrate/glycation cross-linking — only lipid peroxidation products HNE and malondialdehyde are discussed), so that half of the claim is not supported by this source; the cross-links shown are also formed in vitro on a heterologous bacterial model enzyme at 5 mM HNE, with the Discussion conceding basal in vivo HNE concentrations are ~3 orders of magnitude lower. The citing authors' own observation of higher-mass electrophoretic components containing TIMP-3 and vitronectin is not something this paper reports. (LLM, conf=0.70)
- Partly supportedcites [23] Elgawish, A., Glomb, M., Friedlander, M. & Monnier, V. M. R. (1996) J. Biol. Chem. 271, 12964-12971. sourceExperimental — accuracy not yet measured
Our copy of Elgawish et al. (1996) supports the carbohydrate-oxidation half of the attributed point: the Introduction (p.1) notes that 'metal-catalyzed glucose autoxidation may be more important than glycation for generation of fluorescent protein adducts and cross-links' and that deoxyosones/glyoxal and 'reactive ketoaldehydes might be responsible for collagen cross-linking', and the Discussion proposes an H2O2- and Amadori-product-driven covalent lysine-lysine cross-link. The lipid-oxidation half is not asserted by this paper: in the Discussion it appears only as an alternative model ('H2O2 ... could catalyze collagen cross-linking, e.g. through lipid peroxidation (44)'), which the authors immediately discount for their system ('Lipid peroxidation, however, is unlikely to be involved since many studies have shown that it is not preventable by catalase'). The paper also reports no electrophoretic high-mass protein components (its cross-linking readouts are tendon breaking time, linked fluorescence, CML, pentosidine), so it does not address the TIMP-3/vitronectin observation itself. (LLM, conf=0.72)
hedgedstates an associationSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, and serum albumin were the most common proteins observed in normal donor drusen whereas crystallin was detected more frequently in AMD donor drusen.”
- Also stated in: § Results · hedged
“Tissue metalloproteinase inhibitor 3 (TIMP3), clusterin, vitronectin and serum albumin appear to be common drusen proteins, detectable in up to 80% of the tissues from the 18 normal donors”
plainn = 18- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By Western analysis they were found to be more abundant in AMD than in normal Bruch's membrane and were found associated with drusen proteins.”
- Also stated in: § Results · plain
“Western results (Fig. 3) revealed more frequent CEP immunoreactivity among the AMD samples than in the normal controls. Specifically, nine of the 11 AMD samples were immunopositive whereas only two of the 11 age-matched controls were CEP immunoreactive. Statistically these CEP immunoreactivity results are significantly different between AMD and normal donors (Fischer's test, P value = 0.004 single”
plainstates an associationn = 11- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Immunocytochemical studies have thus far localized ≈ 16% of these proteins in drusen.”
- Also stated in: § Discussion · plain
“To verify drusen localization, immunocytochemical studies are ongoing, and to date 21 of the identified proteins (16%) have been confirmed as drusen components in our laboratories and elsewhere.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
20 more claims
Create a free account to see all 39 claims and to verify the 14 references still open.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Biochemical analysis of drusen has identified glycoconjugates and components found in atherosclerotic plaques including vitronectin, apolipoprotein B and E, alpha-crystallin, complement proteins, and lipids (32, 106, 115).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In an AMD patient’s outer retina and plasma, there are more CEP-modified proteins when compared to age-matched controls (Crabb et al., 2002).”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Serum albumin is one of the major proteins modified with CEP”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Biochemical analysis of drusen have indeed resulted in identification of complement components and inflammatory modulators [2–8].”
From CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD (2005) · cites this paper as [8]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“immunize mice with CEP-modified mouse serum albumin, generating a strong immunologic response against endogenous CEP adducts in the outer retina”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“65% (42 ∕ 62) of the proteins identified from AMD donor drusen were found in tissues from normal donors.”
Reported 65 · recomputed 67.741935
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion
“About 38% (41 ∕ 107) of the proteins identified from normal donor drusen were also found in drusen from AMD donors”
§ Discussion
“65% (42 ∕ 62) of the proteins identified from AMD donor drusen were found in tissues from normal donors”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Twenty-one of the 62 proteins detected in drusen from AMD tissue ( ≈ 33%) were not observed in normal donor drusen (Table 3).”
Reported 21 · recomputed 22
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
The Role of Oxidative Stress in the Pathogenesis of Age-Related Macular Degeneration
Beatty, S., Koh, H.-H., Phil, M., Henson, D., & Boulton, M. (2000) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00140-5 · Cited by 2,051
Allikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Chemistry and metabolism of lipids in the vertebrate retina
Fliesler, A. J., & Anderson, R. E. (1983) · Progress in Lipid Research · doi:10.1016/0163-7827(83)90004-8 · Cited by 1,052
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
Ahmed, M. U., Thorpe, S. R., & Baynes, J. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89188-3 · Cited by 864
Identification of the gene responsible for Best macular dystrophy
Petrukhin, K., Koisti, M. J., Bakall, B., Li, W., Xie, G., Marknell, T., Sandgren, O., Forsman, K., Holmgren, G., Andreasson, S., et al. (1998) · Nature Genetics · doi:10.1038/915 · Cited by 689
Positional cloning of the gene associated with X-linked juvenile retinoschisis
Sauer, C. G., Gehrig, A., Warneke-Wittstock, R., Marquardt, A., Ewing, C. C., Gibson, A., Lorenz, B., Jurklies, B., & Weber, B. H. F. (1997) · Nature Genetics · doi:10.1038/ng1097-164 · Cited by 497
Research works printed but not linked: 3
- Midena E., Deglii Angeli, C., Blarzino, M., Valenti, M. & Segato, T. (1997) Invest. Ophthalmol. Visual Sci.38,469-477.9040480
- Kamei M. & Hollyfield, J. E. (1999) Invest. Ophthalmol. Visual Sci.40,2367-2375.10476804
- Handa, J. T., Verzijl, N., Matsunaga, H., Aotaki-Keen, A., Lutty, G. A., te Koppele, J. M., Miyata, T. & Hjelmeland, L. M. (1999) Invest. Ophthalmol. Visual Sci. 40, 775-779.
Cited by
Items 701–800 of 1,000
CEP Biomarkers as Potential Tools for Monitoring Therapeutics
Renganathan, K., Gu, J., Rayborn, M. E., Crabb, J. S., Salomon, R. G., Collier, R. J., Kapin, M. A., Romano, C., Hollyfield, J. G., & Crabb, J. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076325 · Cited by 24
“CEP adducts and CEP autoantibodies were assayed using previously described Western blot, ELISA and immunohistochemistry methods [5,20–22].”
InfluentialSelf-citationErmilov, V. V., & Нестерова, А. А. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17121-0_17 · Cited by 22
A model to study complement involvement in experimental retinal degeneration
Mohlin, C., Sandholm, K., Kvanta, A., Ekdahl, K. N., & Johansson, K. U. I. (2018) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2018.1431744 · Cited by 22
Glenn, J. V., Mahaffy, H., Dasari, S., Oliver, M., Chen, M., Boulton, M., Xu, H., Curry, W. J., & Stitt, A. W. (2011) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1856-9 · Cited by 26
Characterization of semenogelin proteins in the human retina
Bonilha, V. L., Rayborn, M. E., Shadrach, K. G., Lundwall, Å., Malm, J., Bhattacharya, S. K., Crabb, J. W., & Hollyfield, J. G. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.11.011 · Cited by 24
Self-citationAge-Related Macular Degeneration and Retinal Pigment Epithelium Wound Healing
Sugino, I. K., Wang, H., & Zarbin, M. A. (2003) · Molecular Neurobiology · doi:10.1385/mn:28:2:177 · Cited by 24
“Other AMDassociated changes in Bruch’s membrane might be inhibitory to RPE cell resurfacing (89).”
BackgroundProteomics in gerontological research
Schöneich, C. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00035-4 · Cited by 22
Hussain, A. A., Lee, Y., Zhang, J.-J., Francis, P. T., & Marshall, J. (2017) · Journal of Neurodegenerative Diseases · doi:10.1155/2017/4810232 · Cited by 22
Mitra, R. N., Conley, S. M., & Naash, M. I. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17121-0_62 · Cited by 21
“This hypothesis was confirmed when mass spectroscopy revealed multiple oxidized proteins in analyses of druse that were collected from human AMD patients (Crabb et al. 2002).”
BackgroundLipid radicals cause light-induced retinal degeneration
Enoki, M., Shinto, S., Matsuoka, Y., Otsuka, A., Kaidzu, S., Tanito, M., Shibata, T., Uchida, K., Ohira, A., Yamato, M., et al. (2017) · Chemical Communications · doi:10.1039/c7cc03387g · Cited by 21
The effects of zinc supplementation on primary human retinal pigment epithelium
Pao, P.-J., Emri, E., Abdirahman, S. B., Soorma, T., Zeng, H.-H., Hauck, S. M., Thompson, R. B., & Lengyel, I. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.02.028 · Cited by 23
“Apart from APOE we identified a number of other components of sub-RPE deposits [89] in the basal secretome (Supplementary table T1) and some of these were significantly affected by the addition of extracellular zinc (Table1).”
BackgroundPluripotent Stem Cells to Model Degenerative Retinal Diseases: The RPE Perspective
Dalvi, S., Galloway, C. A., & Singh, R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-28471-8_1 · Cited by 21
Zinc Differentially Modulates the Assembly of Soluble and Polymerized Vimentin
Mónico, A., Zorrilla, S., Rivas, G., & Pérez‐Sala, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072426 · Cited by 21
“With respect to pathological aspects, sub-retinal pigment epithelial deposits associated with age-related macular degeneration contain both high concentrations of zinc [47, 48] and vimentin, among other proteins [49-51], which could lead to speculate a role of zinc and vimentin in the formation or progression of these…”
BackgroundKim, D., Choi, Y. R., Shim, J., Choi, Y., Kim, Y. T., Kim, M. K., & Kim, M. J. (2020) · Molecules · doi:10.3390/molecules25071737 · Cited by 22
Rousou, C., Schuurmans, C. C. L., Urtti, A. O., Mastrobattista, E., Storm, G., MOONEN, C. T. W., Kaarniranta, K., & Deckers, R. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111782 · Cited by 24
“Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, serum albumin, crystallin and complement proteins are rich in AMD drusen [71].”
BackgroundMetabolism and Vascular Retinopathies: Current Perspectives and Future Directions
Singh, C. (2022) · Diagnostics · doi:10.3390/diagnostics12040903 · Cited by 21
“(2002) studied proteome of drusen in AMD patients and identified TIMP3, serum albumin, vitronectin, and clusterin as the most frequently found proteins in drusen [62].”
BackgroundPulmonary Disease and Age-Related Macular Degeneration: The Beaver Dam Eye Study
Klein, R., Knudtson, M. D., & Klein, B. E. K. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.6.840 · Cited by 23
Wojciechowski, A. M., Bell, B. A., Song, Y., Anderson, B. D., Conomikes, A., Petruconis, C. R., & Dunaief, J. L. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.110028 · Cited by 20
SirT1 and STAT3 protect retinal pigmented epithelium cells against oxidative stress
Li, L., Wei, W., ZHANG, Y., Tu, G., Zhang, Y., Yang, J., & Xing, Y. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3570 · Cited by 20
Mullins, R. F., Warwick, A., Sohn, E. H., & Lotery, A. J. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx181 · Cited by 22
Enhancing the efficacy of AREDS antioxidants in light-induced retinal degeneration.
WONG, P. W. K., Markey, M. P., Rapp, C. M., Darrow, R. M., Ziesel, A., & Organisciak, D. T. (2017) · PubMed Central · Cited by 23
Microbiota mitochondria disorders as hubs for early age-related macular degeneration
Fehér, J., Élő, Á., István, L., Nagy, Z. Z., Radak, Z. O., Scuderi, G., Artico, M., & Kovács, I. (2022) · GeroScience · doi:10.1007/s11357-022-00620-5 · Cited by 22
Issa, P. C., Scholl, H. P. N., Holz, F. G., Knolle, P. A., & Kurts, C. (2005) · Der Ophthalmologe · doi:10.1007/s00347-005-1269-4 · Cited by 23
Yasukawa, T., Wiedemann, P., Hoffmann, S. R. K., Kacza, J., Eichler, W., Wang, Y., Nishiwaki, A., Seeger, J., & Ogura, Y. (2007) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0571-z · Cited by 21
“In eyes, glycoxidation products are present in lipofuscin, drusen, and Bruch’s membrane of aging eyes, and RPE cells involved in surgically excised CNV membranes [16, 26–28, 30].”
BackgroundInfluentialToomey, C. B., Landowski, M., Klingeborn, M., Kelly, U., Deans, J. R., Dong, H., Harrabi, O., Blarcom, T. J. V., Yeung, Y. A., Grishanin, R. N., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-23134 · Cited by 21
Photoreceptor Degeneration in Aging and Age-Related Maculopathy
Jackson, G. R., Curcio, C. A., Sloan, K. R., & Owsley, C. J. (2005) · Springer eBooks · doi:10.1007/3-540-26977-0_3 · Cited by 21
Sitnilska, V., Enders, P., Cursiefen, C., Fauser, S., & Altay, L. (2020) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-020-04910-6 · Cited by 20
Using Canalography to Visualize the In Vivo Aqueous Humor Outflow Conventional Pathway in Humans
Zeppa, L., Ambrosone, L., Guerra, G., Fortunato, M., & Costagliola, C. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.567 · Cited by 19
Li, H., Chintalapudi, S. R., & Jablonski, M. M. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1369042 · Cited by 23
“Abnormal activation of the complement system is believed to play an important role in atrophic AMD pathogenesis [55,56].”
BackgroundToll-Like Receptors and Age-Related Macular Degeneration
Mulfaul, K., Rhatigan, M., & Doyle, S. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-75402-4_3 · Cited by 20
Būdienė, B., Liutkevičienė, R., Gustienė, O., Ugenskienė, R., Laukaitienė, D., Savukaitytė, A., Vilkevičiūtė, A., Steponavičiūtė, R., Ročytė, A., & Žaliūnienė, D. (2018) · Ophthalmic Genetics · doi:10.1080/13816810.2018.1484928 · Cited by 21
Hollborn, M., Ackmann, C., Kuhrt, H., Doktor, F., Kohen, L., Wiedemann, P., & Bringmann, A. (2018) · PubMed Central · Cited by 21
Mitochondria: The Retina’s Achilles’ Heel in AMD
Ferrington, D. A., Kenney, M. C., Atilano, S. R., Hurley, J. B., Brown, E. E., & Ash, J. D. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-66014-7_10 · Cited by 21
Short-Term Changes of Basal Laminar Drusen on Spectral-Domain Optical Coherence Tomography
van de Ven, J. P., Boon, C. J. F., Smailhodzic, D., Lechanteur, Y. T. E., den Hollander, A. I., Hoyng, C. B., & Theelen, T. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.03.012 · Cited by 22
Proteomics as a research tool in clinical and experimental ophthalmology
Cryan, L. M., & O'Brien, C. J. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780094 · Cited by 20
“Drusen is composed of lipids, polysaccharides, glycosaminoglycans and proteins, and recent studies have analysed the drusen proteome from both normal eyes and those with AMD [38, 39].”
Subchoroidal Release of VEGF and bFGF Produces Choroidal Neovascularization in Rabbit
Wong, C. G., Taban, M., Osann, K., Ross‐Cisneros, F. N., Bruice, T. C., Zahn, G., & You, T. (2016) · Current Eye Research · doi:10.1080/02713683.2016.1227448 · Cited by 20
Adrenomedullin Inhibits Choroidal Neovascularization via CCL2 in the Retinal Pigment Epithelium
Yuda, K., Takahashi, H., Inoue, T., Ueta, T., Iriyama, A., Kadonosono, K., Tamaki, Y., Aburatani, H., Nagai, R., & Yanagi, Y. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.06.028 · Cited by 20
Seeing the light: New insights into the molecular pathogenesis of retinal diseases
Campochiaro, P. A. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21213 · Cited by 23
“Another compelling piece of evidence stems from mass spectroscopy of drusen from postmortem eyes of patients with AMD, which shows many oxidized proteins (Crabb et al., 2002).”
BackgroundWang, H., Ramshekar, A., Kunz, E., & Hartnett, M. E. (2021) · Angiogenesis · doi:10.1007/s10456-021-09770-0 · Cited by 18
“A prevalent oxysterol in Bruch’s membrane and drusen in AMD is 7-ketocholesterol (7KC) [22, 23], which is synthesized in the retina [24] or can form from non-enzymatic oxidation of blood-borne lipids and cholesterol [25, 26].”
BackgroundXiong, Z., Wang, Q., Li, W., Huang, L., Zhang, J., Zhu, J., Xie, B., Wang, S., Kuang, H., Lin, X., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.686886 · Cited by 18
“complement component C3, to generate C3a, C5a and membrane-attacking complex (MAC) C5b-C9, acknowledged in the drusen of AMD patients (Crabb et al., 2002; Mullins et al., 2014; Kim et al., 2020).”
BackgroundMechanobiological implications of age-related remodelling in the outer retina
Piskova, T., Kozyrina, A. N., & Russo, J. D. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213343 · Cited by 20
Associations Between Autoimmune Disease and the Development of Age-Related Macular Degeneration
Moir, J. T., Hyman, M. J., Wang, J. J. J., Shah, A., Maatouk, C. M., Flores, A., & Skondra, D. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.15.45 · Cited by 19
“16 However, it has not been established whether these autoantibodies are intrinsic to the pathogenesis of AMD or if they arise nonspecifically in response to retinal inflammation and damage.”
BackgroundDetection of Retinal Disorders in Optical Coherence Tomography using Deep Learning
Divyansh, R., Padhy, R. P., & Kumar, P. (2019) · International Conference on Computing, Communication and Networking Technologies (ICCCNT) · doi:10.1109/icccnt45670.2019.8944406 · Cited by 21
“Drusen are yellow deposits under the retina, made up of lipids [3].”
BackgroundTherapeutic Potential of α-Crystallins in Retinal Neurodegenerative Diseases
Phadte, A. S., Sluzala, Z. B., & Fort, P. E. (2021) · Antioxidants · doi:10.3390/antiox10071001 · Cited by 18
“Analysis of drusen samples from donor tissue with age-related macular degeneration (AMD) by LCMS revealed a five-fold increase in the levels of αB-crystallin in comparison with donor controls [73].”
BackgroundBai, F., Xi, J.-H., Higashikubo, R., & Andley, U. P. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2004.05.006 · Cited by 18
Lueck, K., Hennig, M., Lommatzsch, A. P., Pauleikhoff, D., & Wasmuth, S. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8889 · Cited by 24
Light Induced and Circadian Effects on Retinal Photoreceptor Cell Crystallins
Organisciak, D. T., Darrow, R. M., Barsalou, L., Rapp, C. M., McDonald, B., & WONG, P. W. K. (2010) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2010.00844.x · Cited by 18
Prevention of retinal light damage by zinc oxide combined with rosemary extract.
Organisciak, D. T., Darrow, R. M., Rapp, C. M., Smuts, J. P., Armstrong, D. W., & Lang, J. C. (2013) · PubMed Central · Cited by 18
König, S., Hadrian, K., Schlatt, S., Wistuba, J., Thanos, S., & Böhm, M. R. R. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.05.016 · Cited by 19
A role for γS‐crystallin in the organization of actin and fiber cell maturation in the mouse lens
Fan, J., Dong, L., Mishra, S., Chen, Y., FitzGerald, P., & Wistow, G. J. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08669.x · Cited by 18
Retinal Pigment Epithelium Differentiation of Stem Cells: Current Status and Challenges
Uygun, B. E., Sharma, N. S., & Yarmush, M. L. (2009) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.v37.i4-5.30 · Cited by 18
Gu, X., Zhang, W., & Salomon, R. G. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0689785 · Cited by 23
Self-citationDentchev, T., Yao, Y., Praticò, D., & Dunaief, J. L. (2007) · PubMed Central · Cited by 18
Wang, H., Linetsky, M. D., Guo, J., Choi, J., Hong, L., Chamberlain, A. S., Howell, S. J., Howes, A. M., & Salomon, R. G. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00001 · Cited by 21
Self-citationShome, I., Thathapudi, N. C., Aramati, B. M. R., Kowtharapu, B. S., & Jangamreddy, J. R. (2023) · International Ophthalmology · doi:10.1007/s10792-023-02767-2 · Cited by 21
“, phospholipids and glycolipids), cholesterol and carbohydrates, drusen also harbor various proteins in significant amounts which include apolipoproteins, vitronectin, clusterin, ubiquitin, fibronectin, integrins, to name among many others [52, 54].”
Backgroundde Carvalho, E. R., Verwoert, M. T., Vogels, I. M. C., Reits, E. A., Noorden, C. J. F. V., Klaassen, I., & Schlingemann, R. O. (2018) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2018.01.005 · Cited by 19
“Drusen contain carbohydrates, zinc and nearly 150 proteins including vitronectin, apolipoproteins E and B, clusterin, connective tissue growth factor (CTGF) and complement system components [3,4].”
BackgroundLashkari, K., Teague, G. C., Beattie, U. K., Betts, J. C., Kumar, S., McLaughlin, M., & López, F. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236283 · Cited by 17
Stravalaci, M., Davi, F., Parente, R., Gobbi, M., Bottazzi, B., Mantovani, A., Day, A. J., Clark, S. J., Romano, M. R., & Inforzato, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.591908 · Cited by 18
Auler, N., Tonner, H., Pfeiffer, N., & Grus, F. H. (2021) · Biology · doi:10.3390/biology10121296 · Cited by 19
“During acute or chronic inflammation, overexpression of C3 is known to occur not only in glaucoma but also in other eye diseases like AMD [87] or DR [88].”
BackgroundInfluentialNivison‐Smith, L., Wang, H., Assaad, N. N., & Kalloniatis, M. (2018) · Optometry and Vision Science · doi:10.1097/opx.0000000000001256 · Cited by 18
Liu, P., Thomson, B. R., Khalatyan, N., Feng, L., Liu, X., Savas, J. N., Quaggin, S. E., & Jin, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807982115 · Cited by 17
“In addition, Vtn of the terminal membrane attack complex is a constituent of ocular drusen in AMD (43).”
BackgroundInfluentialTanito, M., & Anderson, R. E. (2009) · Clinical Lipidology · doi:10.2217/clp.09.65 · Cited by 17
Chen, L., Holland, G. N., Yu, F., Levinson, R. D., Lampi, K. J., Horwitz, J., & Gordon, L. K. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-1971 · Cited by 17
“B1-crystallin was recently identified as a candidate uveitis-associated antigen, in which extralenticular expression was observed in the ciliary body and in drusen.(10,11,24) In this study, we observe a positive association between the presence of serum anti- B1-crystallin antibody and inflammation activity or the pre…”
BackgroundFlupirtine attenuates sodium nitroprusside-induced damage to retinal photoreceptors, in situ
Fawcett, R. J., & Osborne, N. N. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.04.002 · Cited by 17
Glycative stress as a cause of macular degeneration
Bejarano, E., Domenech‐Bendaña, A., Avila-Portillo, N., Rowan, S., Edirisinghe, S., & Taylor, A. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101260 · Cited by 16
Wu, S., Zheng, F., Sui, A., Wu, D., & Chen, Z. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.110050 · Cited by 16
Dalvi, S., Roll, M., Chatterjee, A., Kumar, L. K., Bhogavalli, A., Foley, N., Arduino, C., Spencer, W., Reuben-Thomas, C., Ortolan, D., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.09.006 · Cited by 16
Systemic and Ocular Long Pentraxin 3 in Patients with Age-Related Macular Degeneration
Juel, H. B., Faber, C., Munthe‐Fog, L., Israelsen, S. B., Reese‐Petersen, A. L., Falk, M. K., Singh, A., Sørensen, T. L., Garred, P., & Nissen, M. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132800 · Cited by 17
Anand, A., Sharma, N. K., Singh, R., Gupta, A., Prabhakar, S. K., Jindal, N., Bhatt, A. K., Sharma, S., & Gupta, P. K. (2014) · Scientific Reports · doi:10.1038/srep04114 · Cited by 16
Harvey, H., & Durant, S. (2014) · Experimental Brain Research · doi:10.1007/s00221-014-4078-7 · Cited by 19
“…Aβ1–42 and other molecules that also begin to accumulate in the formation of drusen (for 1 3 a discussion of these, see e.g. Buschini et al. 2011; Crabb et al. 2002; Ding et al. 2009) eventually leads to degeneration of RPE and photoreceptor cells (as discussed in Com‑ mon causal mechanisms),…”
Autophagy activated by SIRT6 regulates Aβ induced inflammatory response in RPEs
Feng, Y., Liang, J., Zhai, Y., Sun, J., Wang, J., She, X., Gu, Q., Liu, Y., Zhu, H., Luo, X., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.159 · Cited by 16
Novel Porcine Retina Cultivation Techniques Provide Improved Photoreceptor Preservation
Wagner, N., Reinehr, S., Gammel, M. R., Greulich, A., Hurst, J., Dick, H. B., Schnichels, S., & Joachim, S. C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.556700 · Cited by 16
“Drusen are located beneath the RPE and consist of many components, such as lipids, amyloid proteins, immune complexes, and complement proteins (Mullins et al., 2000; Crabb et al., 2002).”
BackgroundNanotechnology: revolutionizing the delivery of drugs to treat age-related macular degeneration
Sharma, P., & Mittal, S. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1888925 · Cited by 19
Winiarczyk, M., Winiarczyk, D., Michalak, K., Kaarniranta, K., Adaszek, Ł., Winiarczyk, S., & Mackiewicz, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143060 · Cited by 16
“It was also already found in the aqueous humor of the wet AMD patients (both Annexin A1 and A4) [24], in the drusen from the donors retina [25].”
BackgroundDontsov, A. E., Yakovleva, M. A., Трофимова, Н. Н., Sakina, N. L., Gulin, A. A., Aybush, A. V., Gostev, F. E., Vasin, A., Feldman, T. B., & Оstrovsky, М. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031534 · Cited by 17
“Serum albumin and hemoglobin beta 2 were indeed identified in the composition of drusen obtained from donor eyes of healthy and AMD patients, with a significantly higher concentration in AMD patients [61,65].”
BackgroundEl‐Darzi, N., Mast, N., Buchner, D. A., Saadane, A., Dailey, B., Trichonas, G., & Pikuleva, I. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.902254 · Cited by 16
“, 2014) and common proteins include amyloid β peptides (Aβ) (Mullins et al., 2000; Crabb et al., 2002; Johnson et al., 2002; Luibl et al., 2006; Hoh Kam et al., 2010; Wang et al., 2010), a hallmark of AD that, like AMD, strongly correlates with advanced age and the formation of deposits.”
BackgroundNedić, O., Rogowska-Wrzesińska, A., & Rattan, S. I. S. (2015) · Redox Biology · doi:10.1016/j.redox.2015.04.001 · Cited by 17
“It has also been reported that the concentration of oxidation products in human lens proteins and skin collagen increases along with the accumulation of oxidative forms of alpha-crystallin in patients with age-related cataract [25].”
Handa, J. T., Tagami, M., Ebrahimi, K. B., Leibundgut, G., Janiak, A., Witztum, J. L., & Tsimikas, S. (2015) · Europe PMC (PubMed Central) · Cited by 21
Polarized, Cobblestone, Human Retinal Pigment Epithelial Cell Maturation on a Synthetic PEG Matrix
Tian, Y. I., Zonca, M. R., Imbrogno, J., Unser, A. M., Sfakis, L., Temple, S., Belfort, G., & Xie, Y. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00757 · Cited by 17
Animal models of age-related macular degeneration
Goverdhan, S., Thomson, H. A., & Lotery, A. J. (2013) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2014.03.002 · Cited by 17
Protective inflammasome activation in AMD
Chen, J., & Smith, L. E. H. (2012) · Nature Medicine · doi:10.1038/nm.2761 · Cited by 17
The Challenges and Surprises of Studying the Genetics of Age-Related Macular Degeneration
Traboulsi, E. I. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.01.045 · Cited by 18
Photoreceptor-induced RPE phagolysosomal maturation defects in Stargardt-like Maculopathy (STGD3)
Dejos, C., Kuny, S., Han, W. H., Capel, H. M., Lemieux, H., & Sauvé, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-24357-4 · Cited by 18
Apoptotic Killing of Fibroblasts by Matrix-Bound Advanced Glycation Endproducts
Obrenovich, M. E., & Monnier, V. M. (2005) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2005.4.pe3 · Cited by 16
The Bisretinoids of RPE Lipofuscin: A Complex Mixture
Sparrow, J. R., & Yamamoto, K. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-0631-0_97 · Cited by 15
CFH Haploinsufficiency and Complement Alterations in Early-Onset Macular Degeneration
Lim, R. R., Shirali, S., Rowlan, J. S., Engel, A. L., Nazario, M., Gonzalez, K., Tong, A., Neitz, J., Neitz, M., & Chao, J. R. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.4.43 · Cited by 15
Age-Related Macular Degeneration: A Scientometric Analysis.
Ramin, S., Soheilian, M., Habibi, G., Ghazavi, R., Gharebaghi, R., & Heidary, F. (2015) · Medical Hypothesis Discovery & Innovation in Ophthalmology · Cited by 18
Sistiabudi, R., Paderi, J. E., Panitch, A., & Ivanisevic, A. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.22215 · Cited by 17
Proteomic approach to aging research
Sharov, V. S., & Schöneich, C. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.2.309 · Cited by 15
Photobleaching and Fluorescence Recovery of RPE Bisretinoids
Liu, Z., Ueda, K., Kim, H. J., & Sparrow, J. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138081 · Cited by 15
“These modified proteins can also incite inflammatory processes and, given their presence in drusen [32, 33], probably represent a connection between RPE bisretinoid lipofuscin and the formation of sub-RPE deposits.”
Backgroundγ‐Crystallins of the chicken lens: remnants of an ancient vertebrate gene family in birds
Chen, Y., Sagar, V., Len, H., Peterson, K. M., Fan, J., Mishra, S., McMurtry, J. P., Wilmarth, P. A., David, L. L., & Wistow, G. J. (2016) · FEBS Journal · doi:10.1111/febs.13689 · Cited by 16
Role of Lipids in Retinal Vascular and Macular Disorders
Prakash, G., Agrawal, R., & Natung, T. (2016) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-016-0560-2 · Cited by 18
Wang, H., Han, X., Kunz, E., & Hartnett, M. E. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19691 · Cited by 17
Strunnikova, N., Hilmer, S. C., Flippin, J. D., Robinson, M. R., Hoffman, E. P., & Csaky, K. G. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.04.029 · Cited by 18
Complement C5 is not critical for the formation of sub-RPE deposits in Efemp1 mutant mice
Garland, D. L., Pierce, E. A., & Fernandez-Godino, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-89978-8 · Cited by 14
Vienne-Jumeau, A., Bousquet, E., & Béhar‐Cohen, F. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102616 · Cited by 14
“Drusens contain complement factors such as complement component 3 (C3), complement component 5 (C5), complement component 9 (C9), and the MAC, along with complement regulators like CFH and vitronectin (complement S-protein) [5,15] (Figure 2a,b).”
The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype
Loane, E., Nolan, J. M., McKay, G. J., & Beatty, S. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.07.005 · Cited by 16
“The presence of complement factor proteins in drusen represents yet further evidence that inflammation plays an important role in the pathogenesis of AMD (Crabb et al., 2002; Hollyfield et al., 2008; Johnson et al., 2000).”
BackgroundThomsen, A. K., Steffensen, M. A., Hinnerskov, J. M. V., Nielsen, A. T., Vorum, H., Honoré, B., Nissen, M. H., & Sørensen, T. L. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03273-7 · Cited by 15
“The complement proteins and Cregs C3, C3a, C5a, CD35 and CD46 have been found in drusen, while CD59 + RPE cells was found reduced overlying dru-sen in immunohistochemical analyses [57–60].”
BackgroundOsborne, A. J., Nan, R., Miller, A., Bhatt, J. S., Gor, J., & Perkins, S. J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004767 · Cited by 14
“Drusen contains oxidized lipids, carbohydrates, cellular materials, and over 200 proteins, including FH and other complement components (10, 15, 16).”
BackgroundWolk, A., Upadhyay, M., Ali, M., Suh, J., Stöhr, H., Bonilha, V. L., & Anand‐Apte, B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101681 · Cited by 15
Metadata
- Authors
- Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., Salomon, R. G., & Hollyfield, J. G.
- Affiliations
- Cleveland Clinic (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-10-21
- Volume
- 99
- Issue
- 23
- Pages
- 14682-14687
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC137479
- OpenAlex
- W2136501493
- Semantic Scholar
- 56777252bd03c9f9e59663891e03c8a458996b5f
- Cited by
- 1,208
- References
- 39
- Citations by year
- 2026: 30 · 2025: 40 · 2024: 35 · 2023: 39 · 2022: 52 · 2021: 56 · 2020: 49 · 2019: 34 · 2018: 65 · 2017: 62 · 2016: 44 · 2015: 56 · 2014: 73 · 2013: 57 · 2012: 69
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Foundation Fighting Blindness
- Cleveland Clinic
- Cleveland Clinic Foundation
- National Institutes of Health (5r01ey002362-23, EY06603)
- National Eye Institute (R56EY014240, EY014239, EY06603, EY 014240, F32EY006603, R01EY006603, R01EY014239, EY 02362, R01EY014240)
- National Institute of General Medical Sciences (R01GM021249, GM 21249)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- drusen, age-related macular degeneration, Bruch's membrane, retinal pigment epithelium, protein oxidation, carboxymethyllysine, vitronectin, clusterin, serum albumin, crystallins, drusen formation, AMD pathogenesis
- MeSH terms
- Aged, Aged, 80 and over, Aging, Choroid, Enzymes, Eye, Eye Proteins, Humans, Macular Degeneration, Middle Aged, Reference Values, Retina, Optic Disk Drusen, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.